Cargando…
Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
PURPOSE: Delayed risk stratification (DRS) system by Momesso and coworkers was accepted by the American Thyroid Association as a diagnostic tool for the risk stratification of unfavorable clinical outcomes and to monitor the clinical outcomes of differentiated thyroid cancer (DTC) patients treated w...
Autores principales: | Gąsior-Perczak, Danuta, Pałyga, Iwona, Szymonek, Monika, Kowalik, Artur, Walczyk, Agnieszka, Kopczyński, Janusz, Lizis-Kolus, Katarzyna, Słuszniak, Anna, Słuszniak, Janusz, Łopatyński, Tomasz, Mężyk, Ryszard, Góźdź, Stanisław, Kowalska, Aldona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597973/ https://www.ncbi.nlm.nih.gov/pubmed/28821486 http://dx.doi.org/10.1530/EC-17-0135 |
Ejemplares similares
-
The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2018) -
The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence
por: Kowalska, Aldona, et al.
Publicado: (2016) -
Diagnostic performance evaluation of post-operative serum calcitonin (CT) levels as a factor for good prognosis in medullary thyroid carcinoma (MTC)
por: Gąsior-Perczak, Danuta, et al.
Publicado: (2013) -
The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer
por: Kowalska, Aldona, et al.
Publicado: (2015) -
Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma
por: Szymonek, Monika, et al.
Publicado: (2017)